Device Development for Long-Acting Injectables

18 September 2023 11:40 - 12:10

  • Long-acting injectables improve adherence, efficacy, and quality of life, but oftentimes come with significant device development challenges
  • Novel devices may be desired, which introduce technical, timeline, and usability risks
  • The minimally viable product must be determined, but it is moving target
  • Lifecycle management can be leveraged to balance product complexity and outstanding clinical need

Walter Goodwin, Senior Device Engineer, Gilead Sciences